Performance analysis of PHAXIAM Therapeutics SA ADR (PHXM)
Annual Return
Over the past 3 years, PHXM has had an average annual return of +313.32%, outperforming the benchmark SPY, which returned +19.63% annual.
Since Jun 29, 2023, PHXM has had an average annual return of +56.26%, outperforming the benchmark SPY, which returned +20.56% annual.
| 2026 | 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +313.32% | -5.06% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +313.32% | +0% | +0% | +313.32% | |||||||||
| 2023 | -2.53% | -2.60% | -5.06% |
Drawdown analysis of PHAXIAM Therapeutics SA ADR (PHXM)
The maximum drawdown for the PHXM was -11.39%, occurring on Jul 5, 2023. Recovery took 2 trading sessions.
Since Jun 29, 2023 PHXM has experienced the following drawdowns:
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -11.39% | Jun 29, 2023 | 3 | Jul 5, 2023 | 2 | May 29, 2026 | 5 |